Citryll BV
π³π±Netherlands
- Country
- π³π±Netherlands
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.citryll.com
Clinical Trials
4
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)β’ Click on a phase to view related trials
Phase 2
2 (66.7%)Not Applicable
1 (33.3%)PET-Based Imaging of Radiolabeled CIT-013
Not Applicable
Not yet recruiting
- Conditions
- RA
- Interventions
- Drug: [89Zr]Zr-CIT
- First Posted Date
- 2025-08-29
- Last Posted Date
- 2025-08-29
- Lead Sponsor
- Citryll BV
- Target Recruit Count
- 12
- Registration Number
- NCT07147959
A Study With CIT-013 in HS Patients
Phase 2
Not yet recruiting
- Conditions
- Hidradenitis Suppurativa (HS)
- Interventions
- Drug: CIT-013 high doseDrug: CIT-013 medium doseDrug: Placebo
- First Posted Date
- 2025-05-28
- Last Posted Date
- 2025-07-20
- Lead Sponsor
- Citryll BV
- Target Recruit Count
- 96
- Registration Number
- NCT06993233
- Locations
- π³π±
Erasmus UMC, Rotterdam, Netherlands
A Study With CIT-013 in RA Patients
Phase 2
Recruiting
- Conditions
- Rheumatoid Arthritis
- Interventions
- Drug: CIT-013 low doseDrug: CIT-013 high doseDrug: PlaceboDrug: CIT-013 medium dose
- First Posted Date
- 2024-08-22
- Last Posted Date
- 2025-09-09
- Lead Sponsor
- Citryll BV
- Target Recruit Count
- 88
- Registration Number
- NCT06567470
- Locations
- π§πͺ
Site BE-01, Leuven, Belgium
π©πͺDE-04, Bamberg, Germany
π©πͺDE-05, Berlin, Germany
News
No news found